Raymond James Financial Services Advisors’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
PWAM
Raymond James Financial Services Advisors's FLGT Position: Q4 2023 in Review
Raymond James Financial Services Advisors sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 9,197 shares — an estimated $246K sold.
Raymond James Financial Services Advisors first reported a position in FLGT in Q2 2020 and held it in 14 quarters. The position peaked at $2.31M in Q1 2021. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.
- Raymond James Financial Services Advisors reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
- Raymond James Financial Services Advisors sold 9,197 Fulgent Genetics shares in Q4 2023, an estimated $246K.
- Raymond James Financial Services Advisors first reported a position in Fulgent Genetics in Q2 2020 and held it in 14 quarters.
- Raymond James Financial Services Advisors's Fulgent Genetics position peaked at $2.31M in Q1 2021.
- 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.
Based on Raymond James Financial Services Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.